[利福平在肾病患者中的动力学] - Suppr | 超能文献

[Rifampicin kinetics in enphropathic subjects].

作者信息

Borghetti A, Di Perna A, Novarini A, Bruschi G, Montanari A

出版信息

G Clin Med. 1970 Nov;51(11):857-76.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Rifampicin kinetics in enphropathic subjects].[利福平在肾病患者中的动力学]

G Clin Med. 1970 Nov;51(11):857-76.

2

[Active treatment of renal disease in Finland].[芬兰对肾脏疾病的积极治疗]

Duodecim. 1995;111(15):1497-504.

3

How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?随着终末期肾病的出现和透析的开始，慢性药物治疗应如何调整？

Semin Dial. 2006 Jan-Feb;19(1):8-24. doi: 10.1111/j.1525-139X.2006.00106.x.

4

[Hepatitis in patients with kidney diseases treated with periodic dialysis].[接受定期透析治疗的肾病患者中的肝炎]

Fracastoro. 1969 May-Jun;62(3):263-6.

5

[Chronic renal failure].[慢性肾衰竭]

Naika. 1965 Jul;16(1):36-9.

6

[Rifampicin therapy: data on the pharmacodynamics of the antibiotic derived from clinical practice].利福平治疗：来自临床实践的抗生素药效学数据

Clin Ter. 1975 Jun 15;73(5):461-4.

7

1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。

Dan Med Bull. 2008 Nov;55(4):186-210.

8

[Urinary excretion of rifampicin in kidney failure when administered alone or together with isoniazid].

Antibiotiki. 1983 Sep;28(9):698-702.

9

[Rifampicin and its clinical use].[利福平及其临床应用]

Wiad Lek. 1971 Jul 1;24(3):233-8.

10

[Pharmacokinetics and renal tolerance of rifampicin].

Lille Med. 1972 Nov;17(10):1366-77.

引用本文的文献

1

Clinical pharmacokinetics of antibiotics in patients with impaired renal function.肾功能受损患者抗生素的临床药代动力学

Clin Pharmacokinet. 1992 Mar;22(3):169-210. doi: 10.2165/00003088-199222030-00002.

2

Clinical pharmacokinetics of rifampicin.

Clin Pharmacokinet. 1978 Mar-Apr;3(2):108-27. doi: 10.2165/00003088-197803020-00002.